Early follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab
Main Authors: | T.J. Van Oostenbrugge, J.F. Langenhuijsen, E. Oosterwijk, O.C. Boerman, S.F. Jenniskens, W.J.G. Oyen, J.J. Fütterer, P.F.A. Mulders |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320339227 |
Similar Items
-
Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC
by: Jeannette C. Oosterwijk-Wakka, et al.
Published: (2015-02-01) -
Potential role of 124I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer
by: Plimack ER, et al.
Published: (2012-11-01) -
Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo
by: Tais Basaco, et al.
Published: (2018-11-01) -
Optimizing Lutetium 177–Anti–Carbonic Anhydrase IX Radioimmunotherapy in an Intraperitoneal Clear Cell Renal Cell Carcinoma Xenograft Model
by: Constantijn H.J. Muselaers, et al.
Published: (2014-06-01) -
Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
by: Egbert Oosterwijk, et al.
Published: (2013-05-01)